Brett Wattles
The Latest
-
CDC Officials Push for More Bird Flu Testing Amid Growing Concerns
The need for increased testing of bird flu among people and animals in the United States has been highlighted by Dr. Nirav Shah, principal deputy director of the US Centers for Disease Control and Prevention (CDC). Shah stressed the importance of vigilance without causing undue alarm, noting the current lack of extensive testing among agricultural workers and livestock. 
The need for increased testing of bird flu among people and animals in the United States has been highlighted by Dr. Nirav Shah, principal deputy director of the US Centers for Disease Control and Prevention (CDC). Shah stressed the importance of vigilance without causing undue alarm, noting the current lack of extensive testing among agricultural workers and livestock. -
Federal Officials Call for Vigilance in Response to Bird Flu Outbreak in 12 States
Federal health officials are urging the public to stay vigilant but not alarmed about the current bird flu outbreak, officially termed "highly pathogenic avian influenza" (HPAI). 
Federal health officials are urging the public to stay vigilant but not alarmed about the current bird flu outbreak, officially termed "highly pathogenic avian influenza" (HPAI). -
Maine Confirms First Fatal Case of Tick-Borne Powassan Virus in 2024
The Maine Center for Disease Control and Prevention (CDC) reported on Thursday the first death from the tick-borne Powassan virus in 2024, occurring in York County. This marks a grim milestone for the state, which has already recorded three confirmed infections of the virus this year, including cases in Kennebec and Lincoln counties. 
The Maine Center for Disease Control and Prevention (CDC) reported on Thursday the first death from the tick-borne Powassan virus in 2024, occurring in York County. This marks a grim milestone for the state, which has already recorded three confirmed infections of the virus this year, including cases in Kennebec and Lincoln counties. -
FDA Panel's Rejection of MDMA Therapy for PTSD Raises Questions and Concerns
The Food and Drug Administration (FDA) advisory committee has rejected the approval of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD). The decision, reached on June 4, has sent ripples through the mental health community, particularly among advocates who had high hopes for the potential of this novel treatment. 
The Food and Drug Administration (FDA) advisory committee has rejected the approval of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD). The decision, reached on June 4, has sent ripples through the mental health community, particularly among advocates who had high hopes for the potential of this novel treatment. -
Danish Authorities Recall South Korean Spicy Noodles Over Health Risks
The Danish Veterinary and Food Administration has announced a recall of three types of South Korean spicy instant noodle products, citing health risks due to their high capsaicin content. 
The Danish Veterinary and Food Administration has announced a recall of three types of South Korean spicy instant noodle products, citing health risks due to their high capsaicin content. -
FDA Warns Against Consuming Diamond Shruumz Microdose Chocolates and Gummies Amid Growing Number of Hospitalizations
The Food and Drug Administration (FDA) has issued a stern warning to consumers, urging them to avoid consuming Diamond Shruumz-brand chocolate bars, cones, and gummies after a dozen people across eight states were hospitalized after eating the products. 
The Food and Drug Administration (FDA) has issued a stern warning to consumers, urging them to avoid consuming Diamond Shruumz-brand chocolate bars, cones, and gummies after a dozen people across eight states were hospitalized after eating the products. -
FDA Panel Endorses Alzheimer's Drug Donanemab Despite Safety Concerns
The Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee has unanimously recommended the approval of the Alzheimer's drug donanemab. 
The Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee has unanimously recommended the approval of the Alzheimer's drug donanemab. -
Elephants Use Unique Names to Communicate, Study Reveals
In a groundbreaking discovery, researchers have found that elephants address each other by unique, individual names, suggesting a complex level of social communication previously thought to be exclusive to humans. 
In a groundbreaking discovery, researchers have found that elephants address each other by unique, individual names, suggesting a complex level of social communication previously thought to be exclusive to humans. -
FDA Elevates Noodle Recall to Highest Risk Level Due to Undeclared Egg Allergen
The recall of Sun Noodle's S&S Cup Saimin-Noodles With Soup & Garnishes, due to the undeclared presence of egg, has been reclassified as a Class I recall by the Food and Drug Administration (FDA), marking it as the most severe type of recall under the agency's guidelines. This classification indicates a "reasonable probability" that use or exposure to the product could cause serious adverse health consequences or death. 
The recall of Sun Noodle's S&S Cup Saimin-Noodles With Soup & Garnishes, due to the undeclared presence of egg, has been reclassified as a Class I recall by the Food and Drug Administration (FDA), marking it as the most severe type of recall under the agency's guidelines. This classification indicates a "reasonable probability" that use or exposure to the product could cause serious adverse health consequences or death. -
Several States Struggle with Rising PFAS Drinking Water Contamination
The United States faces a growing challenge with perfluoroalkyl and polyfluoroalkyl substances (PFAS) contamination, a crisis particularly acute in states like New Jersey, Massachusetts, California, New Hampshire, and Pennsylvania. 
The United States faces a growing challenge with perfluoroalkyl and polyfluoroalkyl substances (PFAS) contamination, a crisis particularly acute in states like New Jersey, Massachusetts, California, New Hampshire, and Pennsylvania.
